Biolevate's raises €6M to helps medical writers keep up with the pace of new drugs [Yahoo! Finance]
COLOPLAST AS SP/ADR (CLPBY)
NASDAQ:AMEX Investor Relations:
coloplast.com/investor-relations
Company Research
Source: Yahoo! Finance
Paris-based Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assisting in writing. It's now raised €6 million in a Seed funding round led by EQT Ventures. CEO Joel Belafa told TechCrunch: “Nathan Chen (COO) and I have been friends for 25 years. We have long shared the same professional frustrations with how slow and difficult R&D and market access were for therapeutic products, as well as the severe impact this had on patients and the economy in general.” Even as the pace of drug development is being assisted with the help of AI, the biotech industry still needs to document it all, and this is a laggard sector right now. There's a huge administrative burden on pharma companies that must create documentation to satisfy regulators. By combining Chen's understanding of pharmaceutical processes (learned at Danish healthcare company Coloplast) with Belafa's expertise in AI for enterprises (from being employee number 20 at French A
Show less
Read more
Impact Snapshot
Event Time:
CLPBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLPBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLPBY alerts
High impacting COLOPLAST AS SP/ADR news events
Weekly update
A roundup of the hottest topics
CLPBY
News
- Coloplast A/S (OTCMKTS: CLPBY) was upgraded by analysts at UBS Group AG from a "strong sell" rating to a "hold" rating.MarketBeat
- Biolevate's raises €6M to helps medical writers keep up with the pace of new drugs [TechCrunch]TechCrunch
- Coloplast A/S (OTCMKTS: CLPBY) was upgraded by analysts at Hsbc Global Res from a "moderate sell" rating to a "hold" rating.MarketBeat
- North America Ostomy Drainage Bags (Colostomy, Ileostomy, and Urostomy) Market Outlook 2023-2024 & 2028 with Competitive Analysis of Coloplast, ConvaTec, B. Braun, Hollister, and Salts Healthcare [Yahoo! Finance]Yahoo! Finance
- CMS Confirms Coverage of Kerecis Fish-Skin Products by Medicare [Yahoo! Finance]Yahoo! Finance